Using a pre/post comparative design, a DMO was placed on OR and critical care surfaces of patients who had prolonged cardiovascular procedures and/or extracorporeal membrane oxygenation, Ventricular Assist Device, and/or Heart or Lung transplant. Data collected included: HAPI rates, related costs and staff satisfaction. Descriptive statistics were used to summarize data.
Our results demonstrated a reduction of OR-related HAPI over 6 months from 8/71 (8.5%) to 0/147 (0%). This resulted in a OR-related HAPI cost avoidance of $368,000 (HAPI X 8 @ $46,000); when annualized, $1,472,000 cost avoidance is projected. OR staff satisfaction surveys demonstrated positive results with a mean of 3.85 (1-4). In Critical Care, 12% (8 /7) HAPI incidence reduction was noted and incidence density decreased from 3.57 to 3.24. No improvement in HAPI monthly prevalence was noted in critical care over the 6 months. However, during the 6 months there were many high-acuity patients in the unit which did not meet inclusion criteria thus influencing the prevalence rates. Staff satisfaction mean was 2.95 (1-4) but staff preferred the overlay compared to the usual care (fluid emersion) surface. A cost savings of 22% was found in critical care using the DMO compared to usual care.
The findings of this study suggest a reduction of HAPI’s and cost savings can be realized utilizing the DMO. This intervention offers an additional pressure injury prevention option for the immobile patient undergoing surgery.